NEWS

Press Releases

Human Longevity, Inc. Signs Collaborative Agreement with King’s College London to Access TwinsUK Registry

HLI Team and Professor Tim Spector, M.D., to Collaborate Using this Unique Registry of more than 11,000 well-Characterized Twins

(LA JOLLA, CA) November 13, 2014—Human Longevity, Inc. (HLI), a biological data-driven human health technology and cell therapy company, today announced a collaborative agreement with King’s College London to access their TwinsUK Registry.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Hires Industry Experts Barry Merriman, Ph.D., and Paul Mola, M.S. to Lead New Global Solutions Initiative

(LA JOLLA, CA) October 31, 2014—Human Longevity, Inc. (HLI), a biological data-driven human health technology and cell therapy company, today announced the addition of Barry Merriman, Ph.D., as Vice President of Global Technology Assessment and Paul Mola, M.S. as Head of Global Solutions. The two will work together in HLI’s new Global Solutions Initiative to seek strategic business opportunities worldwide.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Partner Releases

Human Longevity Inc. Adds PacBio(R) Sequencing to Enable Additional Insight Into Human Genetic Variation

Purchase of Two PacBio RS II Sequencing Systems Will Be Used to Help Build HLI’s Genotype/Phenotype Database

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. and Celgene Cellular Therapeutics Sign License Agreement to Develop and Commercialize Placental Stem Cell Population, PSC-100 for Multiple Therapeutic Applications

Celgene Makes Equity Investment in HLI

(LA JOLLA, CA) August 11, 2014—Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, today announced it has signed an agreement with Celgene Cellular Therapeutics (CCT) to license, develop, and co-promote Celgene’s proprietary placental cell population, PSC-100.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist

(LA JOLLA, CA) July 29, 2014—Human Longevity, Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, today announced they have hired Franz Och, Ph.D., an expert in machine learning and machine translation as the company’s Chief Data Scientist. Och comes to HLI from Google where he was Distinguished Research Scientist and the Head of Google Translate. He will report directly to HLI Co-Founder and CEO, J. Craig Venter, Ph.D.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Supports Medical Innovation to Advance the Treatment of Cancer and Other Diseases

HLI Co-Founder, Robert Hariri Speaks on Medical Innovation at 2014 BIO International Convention in San Diego

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity Inc. Hires Renowned Clinical, Regulatory/Scientific and Informatics Leaders

Brad Perkins, MD, MBA, Named Chief Medical Officer; Yaron Turpaz, PhD, MBA, is Chief Information Officer; and Felix Frueh, PhD, joins as Chief Scientific Officer

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

CorTechs Labs and Human Longevity Inc. to Collaborate on Comprehensive Diagnostics by Combining Deep Sequencing with Quantitative Imaging

SAN DIEGO, May 14, 2014 /PRNewswire/ — CorTechs Labs, the leading provider of quantitative medical imaging solutions and Human Longevity Inc. (HLI), a genomics and cell therapy-based diagnostic and therapeutic company focused on extending the healthy, high performance human life span, have signed a collaborative agreement to use CorTech’s advanced imaging data in the comprehensive genomic and phenotype database HLI is building. HLI’s database is a key component in their goal to better understand and intervene in diseases associated with human biological decline. Financial details of the agreement were not disclosed.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity Inc. (HLI) Launched to Promote Healthy Aging Using Advances in Genomics and Stem Cell Therapies

HLI is Building World’s Largest Genotype/Phenotype Database by Sequencing up to 40,000 Human Genomes/Year Combined with Microbiome, Metabolome and Clinical Data to Develop Life Enhancing Therapies

HLI has Purchased Two Illumina HiSeq X Ten Sequencing Systems

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets